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Membrane destabilization by monomeric hIAPP
observed by imaging fluorescence correlation
spectroscopy†
Nirmalya Bag,a Ashraf Ali,b Virander Singh Chauhan,b Thorsten Wohland*a and
Aseem Mishra*b
Monomeric hIAPP significantly destabilizes both model and live
cell membranes by increasing membrane fluidity. This interaction
with membranes happens via carpet formation followed by lipid
extraction in a concentration dependent manner and thus we
propose that hIAPP aggregation prior to membrane interaction
may not be necessary for its cytotoxicity.
Membrane association of aggregation-prone proteins and peptides
has emerged as a critical factor in numerous degenerative diseases.
In the last two decades, human Islet Amyloid Polypeptide (hIAPP)
was shown to be an important amyloidogenic peptide implicated in
progressive pancreatic degeneration in diabetes mellitus type II.
hIAPP is a 37-residue peptide hormone that is co-packaged and
co-secreted with insulin upon glucose stimulus and has been found
to regulate physiological processes viz. gastric emptying and
regulation of insulin response.1 Of particular interest is the
observation that in vitro aggregation of hIAPP causes membrane
damage by a ‘pore formation’ mechanism that is believed to
cause cytotoxicity.2 A concern in these assays, however, is the
high concentration of hIAPP used (10–40 mM) at which it
aggregates; while physiological hIAPP exists as a monomer at a
concentration of 20–100 pM.1 Thus, it is imperative to investigate
the mode of interaction of monomeric hIAPP and its effect on
membranes in an attempt to discover the identity of the toxic
entity in the case of pancreatic degeneration.
In this work, we used membrane dynamics as a metric to probe
monomeric hIAPP induced membrane perturbation. We explored
the eﬀect of monomeric hIAPP on the fluidity of diﬀerent supported
lipid bilayers (SLBs) and live cell membranes using single molecule
sensitive imaging total internal reflection-fluorescence correlation
spectroscopy (ITIR-FCS)3,4 and provide a mechanism of the hIAPP–
membrane interaction. The detailed methods are given in the ESI.†
We first establish that hIAPP exists as a monomer at 1 mM
and lower concentrations by a variety of methods. We used
confocal FCS to measure the diﬀusion time (tD) of Atto-R6G
labelled hIAPP (AR6G-hIAPP). FCS can distinguish monomers
and aggregates based on their respective diﬀusion times. The
tD of AR6G-hIAPP was 66  0.6 ms, which corresponds to the
diﬀusion coeﬃcient (D) = 311  5 mm2 s1 at concentrations of
40 nM and 1 mM (blue and green autocorrelation functions
(ACFs) in Fig. 1A respectively). The obtained value of D is in good
agreement with the previous reports for monomeric hIAPP as
measured by confocal FCS and diﬀusion-NMR experiments.5,6
None of the temporal intensity traces of 10 independent measure-
ments on AR6G-hIAPP at each of these concentrations showed any
Fig. 1 Aggregation state of hIAPP. (A) ACFs of AR6G-hIAPP at diﬀerent
concentrations. (B) Intensity traces of 40 nM (blue) and 1 mM (green) AR6G-
hIAPP show no spike indicating the absence of aggregates. (C) Intensity trace of
40 mM (red) AR6G-hIAPP shows a number of spikes indicating the presence of
aggregates (the inset shows the same trace with a magnified y-axis showing a
wide range of diﬀerent intensity peaks). (D) TEM images of monomeric (1 mM)
hIAPP (top left) and the oligomers (top right), protofibrils (bottom left) and fibrils
(bottom right) of hIAPP. (E) The fluorescence spectra of the aggregation sensing
dye pFTAA in the absence (blue open square) and in the presence of 1 mM
(red close square) and 40 mM (black triangle) unlabelled hIAPP.
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intensity spikes supporting the absence of aggregates (Fig. 1B).
However, intensity traces of 40 mMhIAPP contain spikes indicative
of aggregates (Fig. 1C). The existence of aggregates is confirmed by
the right shift of the ACF as aggregates diﬀuse much slower than
the monomeric species (Fig. 1A, red). Next, the TEM image of 1 mM
hIAPP did not show any feature (Fig. 1D, top left). For comparison,
TEM images of oligomers (top right), protofibrils (bottom left)
and fibrils (bottom right) of hIAPP are shown in Fig. 1D. A novel
penta-thiophene dye, pFTAA, that selectively binds to amyloidogenic
oligomers7 did not show any increase in its fluorescence intensity
(Fig. 1E) nor a change in its absorption spectra (Fig. S1A, ESI†) upon
addition of 1 mM unlabeled hIAPP suggesting that hIAPP did not
form oligomers. The conventional thioflavin T assay also did not
show any fibril formation at this concentration (Fig. S1B, ESI†). The
CD spectra of hIAPP at 1 mM concentration (Fig. S1C, ESI,† red)
exhibited a dominant helical component suggesting the absence of
fibrils. At 40 mM hIAPP aggregated into amyloid fibres (Fig. S1D,
ESI†) with b-sheet conformation (Fig. S1C, ESI,† black). Taken
together, these observations suggest that hIAPP remainsmonomeric
in the range of concentrations (40 nM–1 mM) used for this study.
Interaction of unlabelled hIAPP with the rhodamine PE
(RhoPE) labelled SLBs was studied by measuring the lateral
diﬀusion coeﬃcient (D) of the latter at 310 K. Membrane diﬀusion
is a potent reporter of its integrity. The D of the DOPC :DPPC (1 : 1)
SLB which exhibits gel/fluid phase co-existence increased in a time
dependent manner. The D increased from 3.0  0.4 mm2 s1 to
5.8  1.2 mm2 s1 (at 40 min) (Fig. 2A, green). For the same
concentration of peptide, an SLB composed of DOPC :DPPC :Chol
(1 : 1 : 1), a canonical ‘raft mixture’, exhibited a 70% increase in D
(Fig. 2A, red). An SLB composed of DOPC :Chol (5 : 1), however,
showed only 40% increase in D (Fig. 2A, blue) whereas hIAPP had
little eﬀect on a pure DOPC SLB (Fig. 2A, black). We also observed
an almost instantaneous formation of fluorescent structures in
the diﬀerent bilayers upon addition of the peptide (Video 1,
ESI†). As these structures were brightly fluorescent, we infer
that they contain a large number of lipid molecules extracted
from the RhoPE labelled SLB along with the non-labeled
peptide as a non-specific hetero-complex. Though a similar
process has been proposed earlier, we present experimental
evidence that the extraction of lipid aﬀects its stability.8 The
observed increase in membrane fluidity by lipid extraction is
inversely correlated to the ‘free area’ of the membrane (DOPC >
DOPC :Cholesterol > DOPC :DPPC : Chol > DOPC :DPPC). Lipid
extraction from a gel lipid containing SLBs causes much larger
release of free area compared to that of fluid SLBs and thus a
dramatic change in D was observed for DOPC :DPPC SLBs.
The increase inmembrane fluidity was also dependent on the
peptide concentration used (Fig. 2B). Low concentration of
unlabelled hIAPP (50 nM) did not cause any change in D of
the RhoPE labelled DOPC :DPPC (1 : 1) bilayer (3.0 0.4 mm2 s1
at 310 K) suggesting that physiological levels of hIAPP would be
non-damaging to cellular membranes. However, at moderately
higher concentrations (200–500 nM) we found that the peptide
increased fluidity. Higher peptide concentrations (1 mM) resulted in
a still higher increase inmembrane fluidity (D = 5.8 1.2 mm2 s1).
Though intuitive, we demonstrate here that the extraction of lipids
from the bilayer by sub-micromolar hIAPP concentrations results
directly in the increase in membrane fluidity and not necessarily
collapse.
Nevertheless, hIAPP has to interact with the SLB to be able to
extract lipid. To probe the association of the peptide with the SLB,
we added non-damaging concentration of AR6G-hIAPP (50 nM) to
an unlabelled SLB and imaged the system using total internal
reflection fluorescence (TIRF) microscopy. TIRF videography
showed the peptide to form a diﬀusing carpet-like structure over
the membrane (Fig. 2C and Video 2, ESI†). The dark areas in the
image (and in Video 2, ESI†) are areas of membrane defect/collapse
where AR6G-hIAPP does not form a carpet. The apparent diﬀusion
coeﬃcient of the peptide was computed to be 9.03  5.92 mm2 s1,
which was roughly 3 times higher than the free diﬀusing
lipid probe in the membrane suggesting no penetration of hIAPP
(Fig. S2, ESI†). Recent studies indicate that hIAPP can assume beta-
sheet-like structures on artificial surfaces without forming higher
order oligomers/fibres.9 Moreover, the predictions from the Monte
Carlo simulation (using the MCpep server10) suggest that the
insertion of hIAPP into the membrane is not energetically favour-
able (Fig. 2D and Fig. S3, ESI†). hIAPP assumes an amphiphilic
helical structure with two short hydrophobic stretches alternating
with polar patches (Fig. S4, ESI†),11 a conformation that may not
favour its penetration into the membrane but facilitate surface
orientation (as predicted) favoured by local electrostatics as in
ALPS/class A2 domains.12
Monomeric hIAPP did not form pores in liposomes as
observed from the confocal FCS based dye leakage experiments
(the principle of the experiment is given in Fig. S5, ESI†). The dye
was not released from either rhodamine labelled vesicles (RLVs) or
rhodamine entrapping vesicles (RLVs) upon treatment with 1 mM of
unlabelled monomeric hIAPP (Fig. S6A and B, ESI†), rather the
liposomes aggregated. As expected, hIAPP at aggregating concen-
tration (40 mM) caused dye release (Fig. S7, ESI†). We therefore
Fig. 2 Interaction of monomeric hIAPP with SLBs. (A) Percentage increase in D
of diﬀerent RhoPE labelled SLBs upon treatment with unlabelled hIAPP (1 mM).
(B) hIAPP concentration dependent increase in D of the RhoPE labelled DOPC :
DPPC (1 : 1) bilayer. (C) ACFs of the diﬀusing ‘carpet’ of AR6G-hIAPP (blue,
corresponds to the bright region of the TIRF image shown in the inset) and
background (black, corresponds to the dark region of the same image). In the
inset, the TIRF image shows that AR6G-hIAPP carpets only form on the unlabelled
DOPC SLB top (bright), not on the non-membrane region (dark). (D) The
predicted orientation of hIAPP over a membrane by MCPep shows peptide
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believe that monomeric hIAPP associates with the membrane
following the ‘carpet model’ instead of the widely speculated ‘pore
model’.13
We next explored if hIAPP interacts with live cell membranes
in a similar way. DiI-C18 labelled SH-SY5Y membranes in the
absence of hIAPP showed a D of 2.4  0.4 mm2 s1 at 310 K
(Fig. 3A). Unlabelled hIAPP (1 mM) was added to the cells, as
this concentration was suﬃcient to increase membrane fluidity
for a SLB. A time dependent increase in membrane fluidity (D =
4.1  1.2 mm2 s1) in the initial 20 min was observed (Fig. 3A).
Thereafter, brightly fluorescent plasma membrane derived
structures were visible that exhibited an apparently slower D
(Fig. 3B and C). The standard deviation (SD) is a reflection of
cell membrane heterogeneity and is in a typical range of 17–25%
as seen by FCS measurements for the cell membrane.14 For
measurements at later time points, the SD rises to 95% indicating
an increase in heterogeneity after hIAPP interaction (see ESI† for
details). Although difficult to ascertain, these structures might
resemble vacuole like structures formed in b cells upon hIAPP
treatment that are associated with cellular degeneration.15 In our
experiment, the number and size of these structures increased
with time. We show a ‘FCSmovie’ indicating temporal changes in
spatial distribution of D at a region of interest (ROI) with the
described bright structures (Video 3, ESI†). The principle of the
‘FCS movie’ is given in Fig. S8 (ESI†).
To understand the diﬀusion behaviour of the above-
described structures, we utilized the ‘FCS diﬀusion law’ analysis
implemented on ITIR-FCS that identifies confined diﬀusion
from a plot of diﬀusion time versus the observation area.16
Details of the analysis are given in the ESI.† It was interesting
to observe that the FCS diﬀusion law intercept remained close to
zero until 15 min while the fluidity of the membrane increased
during this time (Fig. 3D). Beyond this time, an increase in the
intercept is associated with an overall decrease in D. The positive
intercept indicates the formation of non-penetrable domains.
This correlated well with the appearance of the bright clusters in
the image sequence. Cytotoxicity assay using MTT also indicated
cell death (B80%) after 14 h of incubation with 1 mM hIAPP
suggesting that the observed membrane destabilization is cytotoxic
(Fig. S9, ESI†). These observations suggest that the increase in
fluidity of the plasma membrane by hIAPP induces a quantifiable
biological response in the form of membrane reorganization not
observed in artificial bilayers. Thus from the SLB and live cell
membrane studies, we conclude that monomeric hIAPP interacts
with membranes via dynamic carpet formation followed by lipid
extraction in a concentration dependent manner (Fig. 3E).
Our results suggest that monomeric hIAPP, alone, can
enhance membrane fluidity depending on its concentration
and the membrane composition and also of the live plasma
membranes leading to significant membrane reorganization.
Based on these findings, we propose that monomeric hIAPP can
present itself as a cytotoxic entity beyond a critical concentration;
pre-aggregation per se may not be essential. However, we cannot
exclude the possibility that hIAPP forms oligomers or aggregates
during or after its interaction with the membrane. Nonetheless,
amyloid plaques are implicated in degenerating pancreas of
diabetes mellitus type II patients. We believe that our findings
will prove valuable in the understanding of hIAPP mediated
cellular damage in a new light and aid in the design of relevant
therapeutic interventions.
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Fig. 3 Interaction of monomeric hIAPP with plasma membranes. (A) A time
dependent increase and subsequent decrease in D of DiI labeled plasma
membrane on treatment with 1 mM unlabelled hIAPP. (B) TIRF images of the
lower membrane of hIAPP treated cells (at measured ROI) at diﬀerent time
points. The scale bar is 1 mm. (C) ACFs of the labelled membrane inside and
outside the bright structures. (D) Time dependent increase in FCS diﬀusion law
intercept (t0). The inset shows the diﬀusion law plots at representative time
points. (E) Schematic representation of ‘carpeting’ and lipid extraction by mono-
meric hIAPP.
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